Since RA is characterized by a variation in disease activity and deterioration over time, effects observed in a short-term trial may not be significant in the long-term and a drug which had no short-term effects may prevent complications or progression of the disease over the long-term [10] , [11] .
← all excerpts
Comparative persistence of the TNF antagonists in rheumatoid arthritis--a population-based cohort study.
1
—
—